6VC-28401-18598
1 vaccination
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 197 / DE
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-24
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2020-12-25
Survey response — days 1–6 daily, dose 1MedDRA: Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2021-01-01
- 2021-01-06
- 2021-06-23
- 2021-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Runny nose
Systemic reaction (other): Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release